Anti-thymocyte Globulins for GVHD Prophylaxis After HLA-matched Sibling Stem Cell Transplantation in Patients at 40 Years of Age or More With Hematological Malignancies
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin; Methotrexate; Mycophenolate mofetil
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 25 Nov 2016 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 25 Nov 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
- 10 Nov 2015 Planned End Date changed from 1 Mar 2017 to 1 Nov 2017 as reported by ClinicalTrials.gov record.